Medical University of Lodz

🇵🇱Poland

Country: 🇵🇱Poland

Ownership: Private

Established: 2002-10-01

Employees: 251

Market Cap: -

Website: https://umed.pl

Clinical Trials

The Incretin Effect in Patients With Gestational Diabetes Mellitus

Completed

Conditions: Gestational Diabetes

First Posted Date: 2011-03-03

Last Posted Date: 2011-03-03

Lead Sponsor: Medical University of Lodz

Target Recruit Count: 20

Registration Number: NCT01307995

Locations: 🇵🇱
Departament of Diabetology and Metabolic Diseases, Polish Mothers Research Hospital, Lodz, Poland

Genetic Assessment of the Patients With Metabolic Syndrome

Conditions: Metabolic Syndrome

First Posted Date: 2010-12-31

Last Posted Date: 2011-07-22

Lead Sponsor: Medical University of Lodz

Target Recruit Count: 300

Registration Number: NCT01268696

Locations: 🇵🇱
Department of medical biotechnology Medical University of Lodz, Lodz, Poland

Effect of Montelukast in Asthma in Children

Phase 3

Conditions: Bronchial Asthma

Interventions: Drug: Montelukast sodium.
Drug: Placebo tablet and budesonide

First Posted Date: 2010-12-24

Last Posted Date: 2013-02-07

Lead Sponsor: Medical University of Lodz

Target Recruit Count: 160

Registration Number: NCT01266772

Locations: 🇵🇱
Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland

Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients

Phase 4

Conditions: Kidney Diseases
Coronary Artery Calcification

Interventions: Drug: Vitamin K2+10μg cholecalciferol
Drug: Vitamin D

First Posted Date: 2010-04-12

Last Posted Date: 2010-04-13

Lead Sponsor: Medical University of Lodz

Target Recruit Count: 60

Registration Number: NCT01101698

Locations: 🇵🇱
Department of Nephrology, Hypertension and Kidney Transplantation, Łódź, Poland

Evaluation of the Delay in Asthma Diagnosis in Children From the Lodz Region

Completed

Conditions: Bronchial Asthma

Interventions: Other: medical documentation and telephone interview

First Posted Date: 2010-03-10

Last Posted Date: 2013-02-07

Lead Sponsor: Medical University of Lodz

Target Recruit Count: 907

Registration Number: NCT01084317

Locations: 🇵🇱
Department of Social and Preventive Medicine, Medical University of Lodz, Poland, Department of Pediatrics and Allergy, N. Copernicus Hospital, Medical University of Lodz, Poland, Lodz, Poland

Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites

Phase 4

Conditions: Bronchial Asthma
Allergic Rhinitis

Interventions: Drug: sublingual house dust mites allergen extract
Drug: placebo in sublingual applicator

First Posted Date: 2010-01-20

Last Posted Date: 2013-02-07

Lead Sponsor: Medical University of Lodz

Target Recruit Count: 100

Registration Number: NCT01052610

Locations: 🇵🇱
Department of Pediatrics and Allergy, Lodz, Poland

Simvastatin in Patients With Isolated Arterial Hypertension

Conditions: Hypertension

First Posted Date: 2009-11-23

Last Posted Date: 2009-11-23

Lead Sponsor: Medical University of Lodz

Target Recruit Count: 50

Registration Number: NCT01017835

Locations: 🇵🇱
Departament of Nephrology, Hypertension and Family Medicine, Clinical Hospital of Medical University of Lodz, Lodz, Poland

The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle

Completed

Conditions: Dilated Cardiomyopathy

Interventions: Drug: Tulip

First Posted Date: 2009-11-18

Last Posted Date: 2009-11-18

Lead Sponsor: Medical University of Lodz

Registration Number: NCT01015144

Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics

Phase 1

Completed

Conditions: Bronchial Asthma

Interventions: Drug: Apocynin nebulization

First Posted Date: 2009-10-09

Last Posted Date: 2009-10-09

Lead Sponsor: Medical University of Lodz

Target Recruit Count: 10

Registration Number: NCT00992667

Locations: 🇵🇱
Medical University of Lodz, Lodz, Lodzkie, Poland

Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With Asthma

Phase 2

Conditions: Asthma

Interventions: Drug: formoterol 12 mcg twice daily
Drug: cyklezonid
Drug: montelukast sodium
Drug: placebo

First Posted Date: 2009-08-18

Last Posted Date: 2013-12-10

Lead Sponsor: Medical University of Lodz

Target Recruit Count: 200

Registration Number: NCT00961155

Locations: 🇵🇱
Department of Pediatrics and Allergy, Medical University of Lodz, Poland, Lodz, Poland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy